 

 

 

UUID27SA97BED-A564-46C - -
TCGA-BG-AB C AEGB 5986667305“

III IIIIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIII'IIIIIIII’IIII ed
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
III IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII'“m

FINAL DIAGNOSIS:

PART 1: UTERUS WITH BOTH ADNEXA, 96 GRAMS, TOTAL ABDOMINAL HYSTERECTOMY AND BILATERAL SALPINGO-
OOPHORECTOMY — I M MODERATELY DIFFERENTIATED,
. DOMETRIOID ADENOCARCINOMA OF THE ENDOMETR U ,
A IENUIOLVING 70% OF THE ENDOMETRIAL SURFACE AND PENETRATING LESS THAN 5% OF THE
MYOMETRIUM. .
BACKGROUND OF ATYPICAL COMPLEX HYPERPLASIA.
FOCAL LYMPHOVASCULAR SPACEAIéﬂOUlalgglENT SEEN.
CHRONIC CERVICITIS, NEGATIVE F .
TUBAL CYSTS.
OPIAN TUBES, CLINICALLY RIGHT AND LEFT WITH PARA
SQIALRIES, CLINICALLY RIGHT AND LEFT WITH STROMAL HYPERPLASIA AND SMALL ADENOFIBROMA
WITH CALCIFICATIONS.

wmppw

T 2: CERVIX, ADDITIONAL PIECE, EXCISION — C - ’2
PAR DISTAL PORTION OF CERVIX, NEGATIVE FOR TUMOR. / A 0

\ \ - .
PART 3: LEFT PELVIC LYMPH NODES. EXCISION - R Wm 6% Wmml, Ms 2390/3
FOUR LYMPH NODES, NEGATIVE FOR TUMO . 5H2: 09H
RT 4: RIGHT PELVIC LYMPH NODES, EXCISION -
PA TWO LYMPH NODES, NEGATIVE FOR TUMOR: #43“

-
COMMENT:

Pelvic wash cytology, ‘ Is negative.

CASE SYNOPSIS: .
SYNOPTIC - PRIMARY UTERINE ENDOMETRIAL CARCINOMA & CARCINOSARCOMA : HYSTERECTOMY
SPECIMENS
TUMOR TYPE: Endometroid adenocarcinoma, NOS
HISTOLOGIC GRADE (epithelial neoplasm) [combined architectural and nuclear]:

Moderately differentiated (FIGO 2)
ARCHITECTURAL GRADE:

Moderately differentiated
NUCLEAR GRADE: Grade 2
TUMOR SIZE: Maximum dimension: 40 mm
PERCENT OF ENDOMETRIAL SURFACE INVOLVEMENT:
Anterior endomyometrium: 20 %. Posterior endomyometrium: 50 %
DEPTH OF INVASION: Less than 1/2 thickness of myometrium
ANGIOLYMPHATIC INVASION: Yes
PRE-NEOPLASTIC CONDITIONS:

Simple endometrial hyperplasia with atypia
Number of lymph nodes positive: 0
Total number of lymph nodes examined: 6

LYMPH NODES POSITIVE:
LYMPH NODES EXAMINED:

T STAGE. PATHOLOGIC:

1
INA 2:222, PATHOLOGIC: :NOa
, PATHOLOGI : '
FIGO STAGE: C IA“ applicable

 
  
 

Diagnosis

    

umor

 
  
 
 
  

HIPAA
Prim

 
   
 

Use is
Reviewer Initials

